Drug Profile
VS 5584
Alternative Names: SB-2312; SB-2343; VS-5584Latest Information Update: 11 May 2018
Price :
$50
*
At a glance
- Originator S*BIO
- Developer Verastem
- Class Antineoplastics; Morpholines; Purines; Pyrimidines; Small molecules
- Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors; MTORC1 protein inhibitors; MTORC2 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Lymphoma; Mesothelioma; Solid tumours